[1]
Petrova, N.V., Emelianova, A.G., Tarasov, S.A., Kartashova, N.P. and Glubokova, E.A. 2020. Efficacy of an experimental drug based on technologically processed antibodies in models of influenza infection and secondary bacterial pneumonia: Results of a preclinical study. Patogenez (Pathogenesis). 18, 4 (Dec. 2020), 55-63. DOI:https://doi.org/10.25557/2310-0435.2020.04.55-63.